OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review
Pierluigi Toniutto, Elisa Fumolo, Ezio Fornasiere, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3932-3932
Open Access | Times Cited: 27
Pierluigi Toniutto, Elisa Fumolo, Ezio Fornasiere, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3932-3932
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Risk assessment in liver transplantation for hepatocellular carcinoma: long-term follow-up of a two-centre experience
Chase J. Wehrle, Roma Raj, Marianna Maspero, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 5, pp. 2818-2831
Open Access | Times Cited: 11
Chase J. Wehrle, Roma Raj, Marianna Maspero, et al.
International Journal of Surgery (2024) Vol. 110, Iss. 5, pp. 2818-2831
Open Access | Times Cited: 11
Liver Transplantation for Hepatocellular Carcinoma: How Should We Improve the Thresholds?
Tsuyoshi Shimamura, Ryoichi Goto, Masaaki Watanabe, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 419-419
Open Access | Times Cited: 29
Tsuyoshi Shimamura, Ryoichi Goto, Masaaki Watanabe, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 419-419
Open Access | Times Cited: 29
The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment
Landon L. Chan, Stephen L. Chan
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 4, pp. 909-923
Open Access | Times Cited: 17
Landon L. Chan, Stephen L. Chan
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 4, pp. 909-923
Open Access | Times Cited: 17
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
George Lau, Shuntaro Obi, Jian Zhou, et al.
Hepatology International (2024) Vol. 18, Iss. 6, pp. 1661-1683
Open Access | Times Cited: 8
George Lau, Shuntaro Obi, Jian Zhou, et al.
Hepatology International (2024) Vol. 18, Iss. 6, pp. 1661-1683
Open Access | Times Cited: 8
Machine Learning-Based Assessment of Survival and Risk Factors in Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma for Optimized Patient Management
Miguel Suárez, Sergio Gil-Rojas, Pablo Martínez-Blanco, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1114-1114
Open Access | Times Cited: 7
Miguel Suárez, Sergio Gil-Rojas, Pablo Martínez-Blanco, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1114-1114
Open Access | Times Cited: 7
MASLD-Related HCC: A Comprehensive Review of the Trends, Pathophysiology, Tumor Microenvironment, Surveillance, and Treatment Options
Yuming Shi, Erfan Taherifard, A.I. Saeed, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5965-5983
Open Access | Times Cited: 7
Yuming Shi, Erfan Taherifard, A.I. Saeed, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5965-5983
Open Access | Times Cited: 7
Role of sex in liver tumor occurrence and clinical outcomes: A comprehensive review
Pierluigi Toniutto, Sarah Shalaby, Laura Mameli, et al.
Hepatology (2023) Vol. 79, Iss. 5, pp. 1141-1157
Open Access | Times Cited: 14
Pierluigi Toniutto, Sarah Shalaby, Laura Mameli, et al.
Hepatology (2023) Vol. 79, Iss. 5, pp. 1141-1157
Open Access | Times Cited: 14
Current Trends and Advancements in the Management of Hepatocellular Carcinoma
Andreas Teufel, Masatoshi Kudo, Yuquan Qian, et al.
Digestive Diseases (2024) Vol. 42, Iss. 4, pp. 349-360
Closed Access | Times Cited: 5
Andreas Teufel, Masatoshi Kudo, Yuquan Qian, et al.
Digestive Diseases (2024) Vol. 42, Iss. 4, pp. 349-360
Closed Access | Times Cited: 5
Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review
Sang Jin Kim, Jong Man Kim
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 739-753
Open Access | Times Cited: 22
Sang Jin Kim, Jong Man Kim
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 739-753
Open Access | Times Cited: 22
Prognostic role of selection criteria for liver transplantation in patients with hepatocellular carcinoma: Review and bibliometric
Pamela Scarlett Espinoza Loyola, D. Bautista, Karen Adela Hernández Bautista, et al.
iLiver (2024) Vol. 3, Iss. 1, pp. 100077-100077
Open Access | Times Cited: 3
Pamela Scarlett Espinoza Loyola, D. Bautista, Karen Adela Hernández Bautista, et al.
iLiver (2024) Vol. 3, Iss. 1, pp. 100077-100077
Open Access | Times Cited: 3
Challenges related to clinical decision-making in hepatocellular carcinoma recurrence post-liver transplantation: Is there a hope?
Nourhan Badwei
World Journal of Transplantation (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 3
Nourhan Badwei
World Journal of Transplantation (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 3
Treatment of hepatocellular carcinoma in sub-Saharan Africa: challenges and solutions
Eduard Jonas, M. Bernon, Barbara Robertson, et al.
The Lancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 11, pp. 1049-1060
Closed Access | Times Cited: 14
Eduard Jonas, M. Bernon, Barbara Robertson, et al.
The Lancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 11, pp. 1049-1060
Closed Access | Times Cited: 14
An inflammatory liquid fingerprint predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
Modan Yang, Zuyuan Lin, Li Zhuang, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 2
Modan Yang, Zuyuan Lin, Li Zhuang, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 2
A Gene Expression Signature to Select Hepatocellular Carcinoma Patients for Liver Transplantation
Hugo P. Marques, Joana Cardoso, Sílvia Silva, et al.
Annals of Surgery (2022) Vol. 276, Iss. 5, pp. 868-874
Open Access | Times Cited: 9
Hugo P. Marques, Joana Cardoso, Sílvia Silva, et al.
Annals of Surgery (2022) Vol. 276, Iss. 5, pp. 868-874
Open Access | Times Cited: 9
Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation
Konstantinos Ouranos, Anthi Chatziioannou, Ioannis Goulis, et al.
World Journal of Transplantation (2022) Vol. 12, Iss. 11, pp. 331-346
Open Access | Times Cited: 7
Konstantinos Ouranos, Anthi Chatziioannou, Ioannis Goulis, et al.
World Journal of Transplantation (2022) Vol. 12, Iss. 11, pp. 331-346
Open Access | Times Cited: 7
Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation
Xu Zhang, Chi Chen, Bin Wang, et al.
Journal of Gastroenterology and Hepatology (2024)
Closed Access | Times Cited: 1
Xu Zhang, Chi Chen, Bin Wang, et al.
Journal of Gastroenterology and Hepatology (2024)
Closed Access | Times Cited: 1
Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation
Meng Sha, Jun Wang, Jie Cao, et al.
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 1
Meng Sha, Jun Wang, Jie Cao, et al.
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 1
Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada
Jason K. Wong, Howard J. Lim, Vincent C. Tam, et al.
Cancer Treatment Reviews (2023) Vol. 115, pp. 102526-102526
Closed Access | Times Cited: 3
Jason K. Wong, Howard J. Lim, Vincent C. Tam, et al.
Cancer Treatment Reviews (2023) Vol. 115, pp. 102526-102526
Closed Access | Times Cited: 3
Special Issue “New Therapies of Liver Diseases”
Pierluigi Toniutto
Journal of Clinical Medicine (2022) Vol. 11, Iss. 7, pp. 1798-1798
Open Access | Times Cited: 3
Pierluigi Toniutto
Journal of Clinical Medicine (2022) Vol. 11, Iss. 7, pp. 1798-1798
Open Access | Times Cited: 3
Understanding the role of radiologists in complex treatment decisions for patients with hepatocellular carcinoma
Omar Kamal, Natally Horvat, Sandeep Arora, et al.
Abdominal Radiology (2023) Vol. 48, Iss. 12, pp. 3677-3687
Closed Access | Times Cited: 1
Omar Kamal, Natally Horvat, Sandeep Arora, et al.
Abdominal Radiology (2023) Vol. 48, Iss. 12, pp. 3677-3687
Closed Access | Times Cited: 1
Liver transplantation for hepatocellular carcinoma: a proposal for including preoperative serological indicators improves the Milan criteria expanded
Ning Jiao, Cheng Yan, He Li, et al.
Research Square (Research Square) (2024)
Open Access
Ning Jiao, Cheng Yan, He Li, et al.
Research Square (Research Square) (2024)
Open Access
Development of a deep learning model for predicting recurrence of hepatocellular carcinoma after liver transplantation
Seung Hyoung Ko, Jie Cao, Yong-kang Yang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Seung Hyoung Ko, Jie Cao, Yong-kang Yang, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
The Equitable Benefit Approach to guide the assessment of medical and psychosocial factors in liver transplant candidacy
Lucia Craxì, Provvidenza M. Cottone, Darío Sacchini, et al.
Liver International (2024) Vol. 44, Iss. 9, pp. 2263-2272
Closed Access
Lucia Craxì, Provvidenza M. Cottone, Darío Sacchini, et al.
Liver International (2024) Vol. 44, Iss. 9, pp. 2263-2272
Closed Access
Trends of liver transplantation in Asia
Ning Qi Pang, Albert C. Y. Chan, Alfred Wei Chieh Kow
Updates in Surgery (2024)
Closed Access
Ning Qi Pang, Albert C. Y. Chan, Alfred Wei Chieh Kow
Updates in Surgery (2024)
Closed Access
Racial Disparities in Liver Transplant for Hepatitis C-Associated Hepatocellular Carcinoma
Frances J. Bennett, Jessica M. Keilson, Michael K. Turgeon, et al.
Annals of Surgical Oncology (2024)
Closed Access
Frances J. Bennett, Jessica M. Keilson, Michael K. Turgeon, et al.
Annals of Surgical Oncology (2024)
Closed Access
